(Q48489411)

12 February 2018

title

Modulation of human motor cortex excitability by single doses of amantadine. (English)

1 reference

12 February 2018

5

Wolfgang H Oertel

1 reference

12 February 2018

7

Felix Rosenow

1 reference

12 February 2018

author name string

Janine Reis

1

1 reference

12 February 2018

Daniel John

2

1 reference

12 February 2018

Antje Heimeroth

3

1 reference

12 February 2018

Hans-Helge Mueller

4

1 reference

12 February 2018

Torsten Arndt

6

1 reference

12 February 2018

language of work or name

English

0 references

publication date

14 June 2006

1 reference

12 February 2018

published in

Neuropsychopharmacology

1 reference

12 February 2018

volume

31

1 reference

12 February 2018

issue

12

1 reference

12 February 2018

page(s)

2758-2766

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301122

exact match

0 references

cites work

Amantadine kinetics in healthy elderly men: implications for influenza prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Determination of serum amantadine by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Topographic mapping of the human motor cortex with magnetic stimulation: factors affecting accuracy and reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Modulation of use-dependent plasticity by d-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Impairment of motor cortex activation and deactivation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Spinal motor neuron excitability during the silent period after cortical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Motor-learning Impairment by Amantadine in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Motor cortex excitability in focal epilepsies not including the primary motor area--a TMS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Evaluation of amantadine as a releasing agent or uptake blocker for H3-dopamine in rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Excitability of the human motor cortex is enhanced during REM sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Corticocortical inhibition in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

The role of GABA(B) receptors in intracortical inhibition in the human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: a PET - [(11)C]raclopride study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Enhancement of NMDA receptor-mediated synaptic potential evoked in rat medial-amygdala neuron following olfactory bulbectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

The assessment and analysis of handedness: The Edinburgh inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Non-invasive differentiation of motor cortical representation of hand muscles by mapping of optimal current directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Topiramate selectively decreases intracortical excitability in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function--a TMS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Riluzole suppresses motor cortex facilitation in correlation to its plasma level. A study using transcranial magnetic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

The NMDA antagonist memantine affects training induced motor cortex plasticity--a study using transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Inhibitory effect of MK-801 on amantadine-induced dopamine release in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

The toxicologic and pharmacologic properties of amantadine hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Dextromethorphan decreases the excitability of the human motor cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

The effect of lorazepam on the motor cortical excitability in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Dual modulating effects of amphetamine on neuronal excitability and stimulation-induced plasticity in human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Affinity of 1-aminoadamantanes for the σ binding site in post-mortem human frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

Amantadine kinetics in healthy young subjects after long-term dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

7 January 2021

The glutamate antagonist riluzole suppresses intracortical facilitation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

7 January 2021

Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

7 January 2021

Effect of pre-treating rat atria with potassium channel blocking drugs on the electrical and mechanical responses to phenylephrine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

7 January 2021

Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301122

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301122

1 reference

12 February 2018

1 reference

12 February 2018